Key result
Keyar CM noninvasive device yields ~97% fetal heart rate accuracy versus standard CTG with greater mobility.
Why the study?
Conventional cardiotocography for intrapartum fetal monitoring has limitations in mobility, comfort, and usability, especially in low-resource settings, making noninvasive ECG-based alternatives needed.
Does the Keyar CM noninvasive intrapartum monitoring device provide comparable accuracy to standard cardiotocography for assessing fetal heart rate and uterine contractions in laboring women?
Does the Keyar CM noninvasive intrapartum monitoring device provide comparable accuracy to standard cardiotocography for assessing fetal heart rate and uterine contractions in laboring women?
The Keyar CM noninvasive ECG-based device provides highly accurate intrapartum fetal monitoring comparable to standard CTG, offering a portable and comfortable alternative for low-resource settings.
Answers are grounded in this paper and cite their sources.
Supports feasibility of noninvasive intrapartum monitoring; leaves open confirmation of outcomes in randomized trials.
A BSTRACT Background: Conventional cardiotocography (CTG) used for intrapartum fetal monitoring has limitations related to mobility, comfort, and usability, especially in low-resource settings. Noninvasive ECG-based monitoring devices offer a potential alternative. Objectives: To assess the accuracy, feasibility, and usability of the Keyar CM noninvasive intrapartum monitoring device compared with standard ultrasound-based CTG. Methods: A prospective observational study was conducted among 119 laboring women with singleton pregnancies at ≥32 weeks of gestation at AIIMS Bathinda. Simultaneous monitoring using Keyar CM and conventional CTG was performed. Baseline fetal heart rate, accelerations, decelerations, and uterine contractions were compared across four time intervals. Accuracy was assessed using percentage agreement and inter-rater reliability. Results: The average accuracy of baseline fetal heart rate, accelerations, decelerations, and uterine contractions recorded by Keyar CM compared with CTG was 96.80%, 80.36%, 93.98%, and 84.07%, respectively. The device demonstrated high agreement with CTG while allowing greater maternal mobility and comfort. Conclusion: Keyar CM shows comparable accuracy to conventional CTG for intrapartum monitoring and offers a portable, noninvasive, and patient-friendly alternative, particularly suitable for low-resource and high-burden settings.
No takes yet. Share an insight, caveat, or question.
Goyal et al. (2026) studied this question. Keyar CM noninvasive intrapartum device showed 96.8% accuracy for fetal heart rate and over 80% for contractions versus standard CTG, offering greater mobility and comfort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: